Preferred Label : dalteparin sodium;
UMLS semantic type : T118 - Carbohydrate; T121 - Pharmacologic Substance;
CAS number : 12M44VTJ7B;
Is substance : O;
UNII : 12M44VTJ7B;
Origin ID : M0027163;
UMLS CUI : C0282471;
Currated CISMeF NLP mapping
- Exact mapping(s) to DCI
- Related record
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3468556/fr/fragmine-dalteparine-sodique-cardiovasculaire
2023
false
false
false
France
evaluation of the transparency committee
dalteparin
dalteparin sodium
Dalteparin Sodium
fragmin
Cardiovascular
Dalteparin Sodium
Murine Cardiovascular System
Cardiovascular System
---
http://www.has-sante.fr/portail/jcms/c_1721870/fr/fragmine
2014
France
French
evaluation of the transparency committee
dalteparin
dalteparin sodium
injections, subcutaneous
insurance, health, reimbursement
dalteparin
venous thromboembolism
postoperative complications
fibrinolytic agents
anticoagulants
renal dialysis
venous thrombosis
deep vein thrombosis
deep vein thrombosis
angina, unstable
myocardial infarction
venous thrombosis
secondary prevention
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60521926
2012
France
summary of product characteristics
package leaflet
syringes
dalteparin
injections
dalteparin sodium
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67562982
2012
France
summary of product characteristics
package leaflet
dalteparin sodium
dalteparin
injections
syringes
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62114270
2012
France
summary of product characteristics
package leaflet
dalteparin
injections
dalteparin sodium
syringes
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63398286
2012
France
summary of product characteristics
package leaflet
dalteparin sodium
injections
dalteparin
syringes
---
http://www.has-sante.fr/portail/jcms/c_996390/fragmine-dalteparine-antithrombotique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/fragmine_-_ct-7974.pdf
2010
France
French
secondary prevention
recurrence
dalteparin
dalteparin
insurance, health, reimbursement
treatment outcome
dalteparin
fibrinolytic agents
neoplasms
dalteparin sodium
venous thromboembolism
venous thromboembolism
fibrinolytic agents
injections, subcutaneous
adult
guidelines for drug use
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/fragmine_-_ct-7974.pdf
http://www.has-sante.fr/portail/jcms/c_968494/fragmine
2010
France
French
evaluation of the transparency committee
dalteparin sodium
dalteparin
insurance, health, reimbursement
venous thromboembolism
venous thromboembolism
dalteparin
fibrinolytic agents
adult
neoplasms
injections, subcutaneous
treatment outcome
---
